The importance of preconception counseling and early pregnancy monitoring

Seminars in Reproductive Medicine

Volumn 29, Issue 6, 2011, Pages 557-568

  Saravelos, Sotirios H ^a   Regan, Lesley ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Early pregnancy; preconception counseling; recurrent pregnancy loss

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; CAFFEINE; FOLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; NICOTINE; NONSTEROID ANTIINFLAMMATORY AGENT; TOBACCO SMOKE;

ALCOHOL CONSUMPTION; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BODY MASS; CIGARETTE SMOKING; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG CONTRAINDICATION; FAMILY PLANNING; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; GENETIC COUNSELING; HUMAN; INSULIN RESISTANCE; LOW BIRTH WEIGHT; MATERNAL CARE; MATERNAL SMOKING; NEURAL TUBE DEFECT; OBESITY; OVARY POLYCYSTIC DISEASE; PATIENT COUNSELING; PATIENT MONITORING; PERIODONTAL DISEASE; PERIODONTITIS; PRACTICE GUIDELINE; PRECONCEPTION COUNSELING; PREGNANCY; PREGNANCY COMPLICATION; PREGNANT WOMAN; PREIMPLANTATION EMBRYO; PREIMPLANTATION GENETIC DIAGNOSIS; PREMATURITY; PRURITUS; SPONTANEOUS ABORTION; SWELLING; THROMBOSIS; TREATMENT OUTCOME; UTERUS MALFORMATION;

ABORTION, HABITUAL; FEMALE; GENETIC TESTING; HUMANS; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL CARE; RISK REDUCTION BEHAVIOR;

EID: 83455258633     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0031-1293209     Document Type: Article

References (164)

1. Freda M C., Moos M K., Curtis M. The history of preconception care: evolving guidelines and standards. Matern Child Health J 2006 10 5, Suppl S43-S52
2. Johnson K, Posner S F., Biermann J et al. Recommendations to improve preconception health and health careUnited States. A report of the CDC/ATSDR Preconception Care Work Group; Select Panel on Preconception Care. MMWR Recomm Rep 2006 55 RR-60 1-23
3. Boulet S L., Parker C, Atrash H. Preconception care in international settings. Matern Child Health J 2006 10 5, Suppl S29-S35
4. American Academy of Pediatrics and American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care. 6th ed. Washington, DC ACOG 2007
5. Clinical Knowledge Summaries (CKS). Pre-conceptionadvice and management. NHS. 2007. Available at: http://www.cks.nhs.uk/pre-conception-advice-and- management Accessed May 2011
6. Posner S F., Johnson K, Parker C, Atrash H, Biermann J. The national summit on preconception care: a summary of concepts and recommendations. Matern Child Health J 2006 10 5, Suppl S197-S205
7. Speidel J J., Harper C C., Shields W C. The potential of long-acting reversible contraception to decrease unintended pregnancy. Contraception 2008 78 3 197-200
8. Jauniaux E, Farquharson R G., Christiansen O B., Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 2006 21 9 2216-2222 (Pubitemid 44530592)
9. Li T C., Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update 2002 8 5 463-481 (Pubitemid 35175207)
10. Guideline G T. 17. The Investigation and Treatment of Couples with Recurrent First Trimester and Second Trimester Miscarriage. London, UK Royal College of Obstetricians and Gynaecologists 2011
11. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). Int J Gynaecol Obstet 2002 78 2 179-190
12. The Dutch Society of Obstetrics and Gynecology (NVOG). Guideline Recurrent Miscarriage. Utrecht, The Netherlands The Dutch Society of Obstetrics and Gynaecology (NVOG) 2007
13. Franssen M T., Musters A M., van der Veen F et al. Reproductive outcome after PGD in couples with recurrent miscarriage carrying a structural chromosome abnormality: a systematic review. Hum Reprod Update 2011 17 4 467-475
14. Musters A M., Repping S, Korevaar J C. et al. Pregnancy outcome after preimplantation genetic screening or natural conception in couples with unexplained recurrent miscarriage: a systematic review of the best available evidence. Fertil Steril 2011 95 6 2153-2157 2157 e1-e3
15. Platteau P, Staessen C, Michiels A, Van Steirteghem A, Liebaers I, Devroey P. Preimplantation genetic diagnosis for aneuploidy screening in patients with unexplained recurrent miscarriages. Fertil Steril 2005 83 2 393-397 quiz 525-526 (Pubitemid 40221794)
16. Donoso P, Devroey P. PGD for aneuploidy screening: an expensive hoax? Best Pract Res Clin Obstet Gynaecol 2007 21 1 157-168
17. Laurino M Y., Bennett R L., Saraiya D S. et al. Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors. J Genet Couns 2005 14 3 165-181 (Pubitemid 40909685)
18. Collins J, Diedrich K, Franks S et al, ESHRE Capri Workshop Group. Genetic aspects of female reproduction. Hum Reprod Update 2008 14 4 293-307 (Pubitemid 351858970)
19. Branch D W., Gibson M, Silver R M. Clinical practice. Recurrent miscarriage. N Engl J Med 2010 363 18 1740-1747
20. Carp H JA, Dirnfeld M, Dor J, Grudzinskas J G. ART in recurrent miscarriage: preimplantation genetic diagnosis/screening or surrogacy? Hum Reprod 2004 19 7 1502-1505 (Pubitemid 38997171)
21. Rai R, Regan L. Recurrent miscarriage. Lancet 2006 368 9535 601-611 (Pubitemid 44209184)
22. Carp H, Toder V, Aviram A, Daniely M, Mashiach S, Barkai G. Karyotype of the abortus in recurrent miscarriage. Fertil Steril 2001 75 4 678-682 (Pubitemid 32273502)
23. Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000 73 2 300-304 (Pubitemid 30060363)
24. Rai R S., Regan L, Clifford K et al. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod 1995 10 8 2001-2005
25. Rai R S., Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995 10 12 3301-3304 (Pubitemid 26026541)
26. Grimbizis G F., Camus M, Tarlatzis B C., Bontis J N., Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update 2001 7 2 161-174 (Pubitemid 32208496)
27. Saravelos S H., Cocksedge K A., Li T C. Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal. Hum Reprod Update 2008 14 5 415-429
28. Homer H A., Li T C., Cooke I D. The septate uterus: a review of management and reproductive outcome. Fertil Steril 2000 73 1 1-14 (Pubitemid 30018013)
29. Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod 1997 12 2 387-389 (Pubitemid 27129408)
30. Brigham S A., Conlon C, Farquharson R G. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 1999 14 11 2868-2871 (Pubitemid 29520709)
31. Law K L., Stroud L R., LaGasse L L., Niaura R, Liu J, Lester B M. Smoking during pregnancy and newborn neurobehavior. Pediatrics 2003 111 6 Pt 1 1318-1323 (Pubitemid 36682265)
32. Kendrick J S., Merritt R K. Women and smoking: an update for the 1990s. Am J Obstet Gynecol 1996 175 3 Pt 1 528-535
33. Troe E J., Raat H, Jaddoe V WV et al. Smoking during pregnancy in ethnic populations: the Generation R study. Nicotine Tob Res 2008 10 8 1373-1384
34. Mishra G D., Dobson A J., Schofield M J. Cigarette smoking, menstrual symptoms and miscarriage among young women. Aust N Z J Public Health 2000 24 4 413-420
35. Salihu H M., Sharma P P., Getahun D et al. Prenatal tobacco use and risk of stillbirth: a case-control and bidirectional case-crossover study. Nicotine Tob Res 2008 10 1 159-166
36. Ekblad M, Gissler M, Lehtonen L, Korkeila J. Prenatal smoking exposure and the risk of psychiatric morbidity into young adulthood. Arch Gen Psychiatry 2010 67 8 841-849
37. Newnham J P., Patterson L, James I, Reid S E. Effects of maternal cigarette smoking on ultrasonic measurements of fetal growth and on Doppler flow velocity waveforms. Early Hum Dev 1990 24 1 23-36 (Pubitemid 20344891)
38. Falk L, Nordberg A, Seiger A, Kjaeldgaard A, Hellström-Lindahl E. Smoking during early pregnancy affects the expression pattern of both nicotinic and muscarinic acetylcholine receptors in human first trimester brainstem and cerebellum. Neuroscience 2005 132 2 389-397 (Pubitemid 40417912)
39. Werler M M. Teratogen update: smoking and reproductive outcomes. Teratology 1997 55 6 382-388 (Pubitemid 27424799)
40. Lindbohm M L., Sallmén M, Taskinen H. Effects of exposure to environmental tobacco smoke on reproductive health. Scand J Work Environ Health 2002 28 Suppl 2 84-96 (Pubitemid 34591163)
41. Roza S J., Verburg B O., Jaddoe V WV et al. Effects of maternal smoking in pregnancy on prenatal brain development. The Generation R Study. Eur J Neurosci 2007 25 3 611-617
42. Kline J, Levin B, Kinney A, Stein Z, Susser M, Warburton D. Cigarette smoking and spontaneous abortion of known karyotype. Precise data but uncertain inferences. Am J Epidemiol 1995 141 5 417-427
43. Armstrong B G., McDonald A D., Sloan M. Cigarette, alcohol, and coffee consumption and spontaneous abortion. Am J Public Health 1992 82 1 85-87
44. Windham G C., Swan S H., Fenster L. Parental cigarette smoking and the risk of spontaneous abortion. Am J Epidemiol 1992 135 12 1394-1403
45. Ness R B., Grisso J A., Hirschinger N et al. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med 1999 340 5 333-339 (Pubitemid 29090797)
46. Chatenoud L, Parazzini F, di Cintio E et al. Paternal and maternal smoking habits before conception and during the first trimester: relation to spontaneous abortion. Ann Epidemiol 1998 8 8 520-526 (Pubitemid 28473737)
47. George L, Granath F, Johansson A LV, Olander B, Cnattingius S. Risks of repeated miscarriage. Paediatr Perinat Epidemiol 2006 20 2 119-126
48. Nielsen A, Hannibal C G., Lindekilde B E. et al. Maternal smoking predicts the risk of spontaneous abortion. Acta Obstet Gynecol Scand 2006 85 9 1057-1065 (Pubitemid 44277048)
49. Windham G C., Von, Behren J, Waller K, Fenster L. Exposure to environmental and mainstream tobacco smoke and risk of spontaneous abortion. Am J Epidemiol 1999 149 3 243-247 (Pubitemid 29053164)
50. Anderson K, Norman R J., Middleton P. Preconception lifestyle advice for people with subfertility. Cochrane Database Syst Rev 2010 4 CD008189
51. Rasch V. Cigarette, alcohol, and caffeine consumption: risk factors for spontaneous abortion. Acta Obstet Gynecol Scand 2003 82 2 182-188 (Pubitemid 36349850)
52. Gardella J R., Hill J A. III. Environmental toxins associated with recurrent pregnancy loss. Semin Reprod Med 2000 18 4 407-424 (Pubitemid 32427672)
53. Kesmodel U, Wisborg K, Olsen S F., Henriksen T B., Secher N J. Moderate alcohol intake in pregnancy and the risk of spontaneous abortion. Alcohol Alcohol 2002 37 1 87-92 (Pubitemid 34173315)
54. Florey C D. EUROMAC. A European concerted action: maternal alcohol consumption and its relation to the outcome of pregnancy and child development at 18 months. Methods. Int J Epidemiol 1992 21 Suppl 1 S38-S39
55. Harlap S, Shiono P H. Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester. Lancet 1980 2 8187 173-176 (Pubitemid 10084717)
56. Bakker R, Pluimgraaff L E., Steegers E AP et al. Associations of light and moderate maternal alcohol consumption with fetal growth characteristics in different periods of pregnancy: the Generation R Study. Int J Epidemiol 2010 39 3 777-789
57. Jaddoe V WV, Bakker R, Hofman A et al. Moderate alcohol consumption during pregnancy and the risk of low birth weight and preterm birth. The Generation R study. Ann Epidemiol 2007 17 10 834-840 (Pubitemid 47393631)
58. Parazzini F, Chatenoud L, Di Cintio E et al. Coffee consumption and risk of hospitalized miscarriage before 12 weeks of gestation. Hum Reprod 1998 13 8 2286-2291 (Pubitemid 28425130)
59. Domínguez-Rojas V, de Juanes-Pardo J R., Astasio-Arbiza P, Ortega-Molina P, Gordillo-Florencio E. Spontaneous abortion in a hospital population: are tobacco and coffee intake risk factors? Eur J Epidemiol 1994 10 6 665-668
60. Bech B H., Nohr E A., Vaeth M, Henriksen T B., Olsen J. Coffee and fetal death: a cohort study with prospective data. Am J Epidemiol 2005 162 10 983-990 (Pubitemid 41619469)
61. Tolstrup J S., Kjaer S K., Munk C et al. Does caffeine and alcohol intake before pregnancy predict the occurrence of spontaneous abortion? Hum Reprod 2003 18 12 2704-2710 (Pubitemid 37536644)
62. Matijasevich A, Barros F C., Santos I S., Yemini A. Maternal caffeine consumption and fetal death: a case-control study in Uruguay. Paediatr Perinat Epidemiol 2006 20 2 100-109
63. Infante-Rivard C, Fernández A, Gauthier R, David M, Rivard G E. Fetal loss associated with caffeine intake before and during pregnancy. JAMA 1993 270 24 2940-2943 (Pubitemid 24000800)
64. Weng X, Odouli R, Li D K. Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Am J Obstet Gynecol 2008 198 3 e1-e8
65. de Maeyer J, Schepens P J., Jorens P G., Verstraete R. Exposure to pentachlorophenol as a possible cause of miscarriages. Br J Obstet Gynaecol 1995 102 12 1010-1011 (Pubitemid 26014999)
66. Li D K., Odouli R, Wi S et al. A population-based prospective cohort study of personal exposure to magnetic fields during pregnancy and the risk of miscarriage. Epidemiology 2002 13 1 9-20 (Pubitemid 34031505)
67. Li D K., Janevic T, Odouli R, Liu L. Hot tub use during pregnancy and the risk of miscarriage. Am J Epidemiol 2003 158 10 931-937 (Pubitemid 37413389)
68. Brandt L PA, Nielsen C V. Job stress and adverse outcome of pregnancy: a causal link or recall bias? Am J Epidemiol 1992 135 3 302-311
69. Florack E IM, Zielhuis G A., Pellegrino J E., Rolland R. Occupational physical activity and the occurrence of spontaneous abortion. Int J Epidemiol 1993 22 5 878-884 (Pubitemid 23331098)
70. McDonald A D., McDonald J C., Armstrong B et al. Fetal death and work in pregnancy. Br J Ind Med 1988 45 3 148-157 (Pubitemid 18085002)
71. Aleman A, Althabe F, Belizán J, Bergel E. Bed rest during pregnancy for preventing miscarriage. Cochrane Database Syst Rev 2005 2 CD003576
72. World Health Organisation. United Kingdom: health profile. World Health Organisation (WHO); 2008. Available at: http://www.who.int/gho/countries/gbr.pdf Accessed May 2011
73. World Health Organisation. United States: health profile. World Health Organisation (WHO); 2008. Available at: http://www.who.int/gho/countries/usa.pdf Accessed May 2011
74. Metwally M, Ong K J., Ledger W L., Li T C. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertil Steril 2008 90 3 714-726
75. Sebire N J., Jolly M, Harris J P. et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord 2001 25 8 1175-1182 (Pubitemid 32721540)
76. Metwally M, Tuckerman E M., Laird S M., Ledger W L., Li T C. Impact of high body mass index on endometrial morphology and function in the peri-implantation period in women with recurrent miscarriage. Reprod Biomed Online 2007 14 3 328-334 (Pubitemid 46463631)
77. Cocksedge K A., Li T C., Saravelos S H., Metwally M. A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage. Reprod Biomed Online 2008 17 1 151-160
78. Veleva Z, Tiitinen A, Vilska S et al. High and low BMI increase the risk of miscarriage after IVF/ICSI and FET. Hum Reprod 2008 23 4 878-884
79. Lashen H, Fear K, Sturdee D W. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 2004 19 7 1644-1646 (Pubitemid 38997196)
80. Fedorcsák P, Storeng R, Dale P O., Tanbo T, Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand 2000 79 1 43-48 (Pubitemid 30045290)
81. Bellver J, Rossal L P., Bosch E et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril 2003 79 5 1136-1140 (Pubitemid 36547851)
82. Metwally M, Saravelos S H., Ledger W L., Li T C. Body mass index and risk of miscarriage in women with recurrent miscarriage. Fertil Steril 2010 94 1 290-295
83. Helgstrand S, Andersen A MN. Maternal underweight and the risk of spontaneous abortion. Acta Obstet Gynecol Scand 2005 84 12 1197-1201 (Pubitemid 41719826)
84. Maconochie N, Doyle P, Prior S, Simmons R. Risk factors for first trimester miscarriage-results from a UK-population-based case-control study. BJOG 2007 114 2 170-186 (Pubitemid 46089446)
85. Word Health Organisation. Report of a WHO technical consultation on birth spacing. World Health Organisation (WHO); 2005. Available at: http://whqlibdoc.who.int/hq/2007/WHO-RHR-07.1-eng.pdf Accessed May 2011
86. Love E R., Bhattacharya S, Smith N C., Bhattacharya S. Effect of interpregnancy interval on outcomes of pregnancy after miscarriage: retrospective analysis of hospital episode statistics in Scotland. BMJ 2010 341 c3967
87. Christiansen O B., Nybo, Andersen A M., Bosch E et al. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 2005 83 4 821-839
88. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997 314 7076 253-257 (Pubitemid 27047378)
89. Backos M, Rai R, Baxter N, Chilcott I T., Cohen H, Regan L. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol 1999 106 2 102-107 (Pubitemid 29065223)
90. Empson M, Lassere M, Craig J C., Scott J R. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002 99 1 135-144 (Pubitemid 34075480)
91. Mak I YH, Brosens J J., Christian M et al. Regulated expression of signal transducer and activator of transcription, Stat5, and its enhancement of PRL expression in human endometrial stromal cells in vitro. J Clin Endocrinol Metab 2002 87 6 2581-2588 (Pubitemid 34655317)
92. Bose P, Black S, Kadyrov M et al. Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. Am J Obstet Gynecol 2005 192 1 23-30 (Pubitemid 40164214)
93. Di Simone N, Castellani R, Caliandro D, Caruso A. Antiphospholid antibodies regulate the expression of trophoblast cell adhesion molecules. Fertil Steril 2002 77 4 805-811 (Pubitemid 34275366)
94. Sebire N J., Backos M, El, Gaddal S, Goldin R D., Regan L. Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients. Obstet Gynecol 2003 101 2 258-263 (Pubitemid 36170126)
95. Bose P, Black S, Kadyrov M et al. Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro. Am J Obstet Gynecol 2004 191 6 2125-2131 (Pubitemid 39601524)
96. Dolitzky M, Inbal A, Segal Y, Weiss A, Brenner B, Carp H. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertil Steril 2006 86 2 362-366 (Pubitemid 44118966)
97. Badawy A M., Khiary M, Sherif L S., Hassan M, Ragab A, Abdelall I. Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. J Obstet Gynaecol 2008 28 3 280-284 (Pubitemid 351873805)
98. Mantha S, Bauer K A., Zwicker J I. Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systematic review. J Thromb Haemost 2010 8 2 263-268
99. Kaandorp S, Di, Nisio M, Goddijn M, Middeldorp S. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database Syst Rev 2009 1 CD004734
100. Kaandorp S P., Goddijn M, van der, Post J A. et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010 362 17 1586-1596
101. Li D K., Liu L Y., Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003 327 7411 368-371 (Pubitemid 37000069)
102. Nielsen G L., Skriver M V., Pedersen L, Sørensen H T. Danish group reanalyses miscarriage in NSAID users. BMJ 2004 328 7431 109-109
103. George L, Mills J L., Johansson A LV et al. Plasma foliate levels and risk of spontaneous abortion. JAMA 2002 288 15 1867-1873 (Pubitemid 35168142)
104. Timmermans S, Jaddoe V W., Hofman A, Steegers-, Theunissen R P., Steegers E A. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R study. Br J Nutr 2009 102 5 777-785
105. Mook-Kanamori D O., Steegers E AP, Eilers P H., Raat H, Hofman A, Jaddoe V W. Risk factors and outcomes associated with first-trimester fetal growth restriction. JAMA 2010 303 6 527-534
106. George A, Shamim S, Johnson M et al. Periodontal treatment during pregnancy and birth outcomes: a metaanalysis of randomised trials. Int J Evid-Based Healthcare 2011 9 2 122-147
107. Polyzos N P., Polyzos I P., Mauri D et al. Effect of periodontal disease treatment during pregnancy on preterm birth incidence: a metaanalysis of randomized trials. Am J Obstet Gynecol 2009 200 3 225-232
108. Moore S, Ide M, Coward P Y. et al. A prospective study to investigate the relationship between periodontal disease and adverse pregnancy outcome. Br Dent J 2004 197 5 251-258 discussion 247 (Pubitemid 39278178)
109. Farrell S, Ide M, Wilson R F. The relationship between maternal periodontitis, adverse pregnancy outcome and miscarriage in never smokers. J Clin Periodontol 2006 33 2 115-120 (Pubitemid 43424838)
110. Uppal A, Uppal S, Pinto A et al. The effectiveness of periodontal disease treatment during pregnancy in reducing the risk of experiencing preterm birth and low birth weight: a meta-analysis. J Am Dent Assoc 2010 141 12 1423-1434
111. Khader Y S., Ta'ani Q. Periodontal diseases and the risk of preterm birth and low birth weight: a meta-analysis. J Periodontol 2005 76 2 161-165 (Pubitemid 40542241)
112. Rumbold A, Middleton P, Pan N, Crowther C A. Vitamin supplementation for preventing miscarriage. Cochrane Database Syst Rev 2011 1 CD004073
113. Shah P S., Ohlsson A, Knowledge Synthesis Group on Determinants of Low Birth Weight and Preterm Births. Effects of prenatal multimicronutrient supplementation on pregnancy outcomes: a meta-analysis. CMAJ 2009 180 12 E99-E108
114. van Eijsden M, Hornstra G, van der Wal M F., Vrijkotte T G., Bonsel G J. Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birth weight: a prospective cohort study. Am J Clin Nutr 2008 87 4 887-895 (Pubitemid 351549233)
115. Porter T F., LaCoursiere Y, Scott J R. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006 2 CD000112
116. Haas D M., Ramsey P S. Progestogen for preventing miscarriage. Cochrane Database Syst Rev 2008 2 CD003511
117. Scott J R., Pattison N. Human chorionic gonadotrophin for recurrent miscarriage. Cochrane Database Syst Rev 2000 2 CD000101
118. Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984 148 2 140-146
119. Liddell H S., Pattison N S., Zanderigo A. Recurrent miscarriage-outcome after supportive care in early pregnancy. Aust N Z J Obstet Gynaecol 1991 31 4 320-322
120. Jauniaux E, Jurkovic D, Henriet Y, Rodesch F, Hustin J. Development of the secondary human yolk sac: correlation of sonographic and anatomical features. Hum Reprod 1991 6 8 1160-1166
121. Dickey R P., Gasser R F., Olar T T. et al. Risk of recurrent abortion after appearance of a chorionic sac or heart rate on vaginal ultrasound. Lancet 1994 344 8934 1442-1443 (Pubitemid 24365341)
122. Dickey R P., Gasser R F., Olar T T. et al. The relationship of initial embryo crownrump length to pregnancy outcome and abortus karyotype based on new growth curves for the 2-31 mm embryo. Hum Reprod 1994 9 2 366-373 (Pubitemid 24076765)
123. Stampone C, Nicotra M, Muttinelli C, Cosmi E V. Transvaginal sonography of the yolk sac in normal and abnormal pregnancy. J Clin Ultrasound 1996 24 1 3-9 (Pubitemid 26005169)
124. Makrydimas G, Sebire N J., Lolis D, Vlassis N, Nicolaides K H. Fetal loss following ultrasound diagnosis of a live fetus at 6-10 weeks of gestation. Ultrasound Obstet Gynecol 2003 22 4 368-372 (Pubitemid 37289764)
125. Papaioannou G I., Syngelaki A, Maiz N, Ross J A., Nicolaides K H. Ultrasonographic prediction of early miscarriage. Hum Reprod 2011 26 7 1685-1692
126. Saraswat L, Bhattacharya S, Maheshwari A, Bhattacharya S. Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review. BJOG 2010 117 3 245-257
127. Smith G C., Smith M F., Mc, Nay M B., Fleming J E. First trimester growth and the risk of low birth weight. N Engl J Med 1998 339 25 1817-1822 (Pubitemid 29005786)
128. Bukowski R, Smith G C., Malone F D. et al, FASTER Research Consortium. Fetal growth in early pregnancy and risk of delivering low birth weight infant: prospective cohort study. BMJ 2007 334 7598 836
129. Pedersen N G., Figueras F, Wøjdemann KR, Tabor A, Gardosi J. Early fetal size and growth as predictors of adverse outcome. Obstet Gynecol 2008 112 4 765-771
130. Smith G CS. First-trimester determination of complications of late pregnancy. JAMA 2010 303 6 561-562
131. Law L W., Leung T Y., Sahota D S., Chan L W., Fung T Y., Lau T K. Which ultrasound or biochemical markers are independent predictors of small-for-gestational age? Ultrasound Obstet Gynecol 2009 34 3 283-287
132. Plasencia W, Maiz N, Poon L, Yu C, Nicolaides K H. Uterine artery Doppler at 11+0 to 13+6 weeks and 21+0 to 24+6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2008 32 2 138-146
133. Poon L CY, Stratieva V, Piras S, Piri S, Nicolaides K H. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks. Prenat Diagn 2010 30 3 216-223
134. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides K H. Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2007 30 5 742-749 (Pubitemid 47612696)
135. Leunissen R W., Kerkhof G F., Stijnen T, Hokken-Koelega A. Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA 2009 301 21 2234-2242
136. Ekelund U, Ong K K., Linné Y et al. Association of weight gain in infancy and early childhood with metabolic risk in young adults. J Clin Endocrinol Metab 2007 92 1 98-103 (Pubitemid 46067515)
137. Ekelund U, Ong K, Linné Y et al. Upward weight percentile crossing in infancy and early childhood independently predicts fat mass in young adults: the Stockholm Weight Development Study (SWEDES). Am J Clin Nutr 2006 83 2 324-330 (Pubitemid 44713194)
138. Fagerberg B, Bondjers L, Nilsson P. Low birth weight in combination with catch-up growth predicts the occurrence of the metabolic syndrome in men at late middle age: the Atherosclerosis and Insulin Resistance study. J Intern Med 2004 256 3 254-259 (Pubitemid 39222995)
139. Ramadhani M K., Grobbee D E., Bots M L. et al. Lower birth weight predicts metabolic syndrome in young adults: the Atherosclerosis Risk in Young Adults (ARYA) study. Atherosclerosis 2006 184 1 21-27 (Pubitemid 41721065)
140. Vos L E., Oren A, Bots M L., Gorissen W H., Grobbee D E., Uiterwaal C S. Birth size and coronary heart disease risk score in young adulthood. The Atherosclerosis Risk in Young Adults (ARYA) study. Eur J Epidemiol 2006 21 1 33-38 (Pubitemid 43188728)
141. Geelhoed J JM, Verburg B O., Nauta J et al. Tracking and determinants of kidney size from fetal life until the age of 2 years: the Generation R study. Am J Kidney Dis 2009 53 2 248-258
142. Poon L C., Akolekar R, Lachmann R, Beta J, Nicolaides K H. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks. Ultrasound Obstet Gynecol 2010 35 6 662-670
143. Goetzinger K R., Singla A, Gerkowicz S, Dicke J M., Gray D L., Odibo A O. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders. Am J Obstet Gynecol 2009 201 4 412; e1-e6
144. Goetzinger K R., Singla A, Gerkowicz S, Dicke J M., Gray D L., Odibo A O. Predicting the risk of pre-eclampsia between 11 and 13 weeks' gestation by combining maternal characteristics and serum analytes, PAPP-A and free b-hCG. Prenat Diagn 2010 30 12-13 1138-1142
145. Cusick W, Rodis J F., Vintzileos A M., Albini S M., McMahon M, Campbell W A. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation. J Reprod Med 1996 41 5 327-332
146. Williams M A., Hickok D E., Zingheim R W., Mittendorf R, Kimelman J, Mahony B S. Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1992 80 5 745-749
147. Chandra S, Scott H, Dodds L, Watts C, Blight C, Van Den Hof M. Unexplained elevated maternal serum alphafetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes. Am J Obstet Gynecol 2003 189 3 775-781 (Pubitemid 37194104)
148. Spencer K, Cowans N J., Chefetz I, Tal J, Meiri H. First trimester maternal serum PP-13, PAPP-A and secondtrimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol 2007 29 2 128-134 (Pubitemid 46326583)
149. Odibo A O., Zhong Y, Longtine M et al. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction. Placenta 2011 32 4 333-338
150. Pilalis A, Souka A P., Antsaklis P et al. Screening for preeclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation. Ultrasound Obstet Gynecol 2007 29 2 135-140 (Pubitemid 46326584)
151. Nicolaides K H., Bindra R, Turan O M. et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol 2006 27 1 13-17 (Pubitemid 43129084)
152. Venkat-Raman N, Backos M, Teoh T G., Lo W TS, Regan L. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome. Obstet Gynecol 2001 98 2 235-242 (Pubitemid 32744755)
153. Smith G CS. First trimester origins of fetal growth impairment. Semin Perinatol 2004 28 1 41-50 (Pubitemid 38298828)
154. Eckert J P., Fleming T P. SAC review: The effect of nutrition and environment on the preimplantation embryo. Obstetrician Gynaecol 2011 13 1 43-48
155. Kwong W Y., Wild A E., Roberts P, Willis A C., Fleming T P. Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development 2000 127 19 4195-4202
156. Bloomfield F H., Oliver M H., Hawkins P et al. A periconceptional nutritional origin for noninfectious preterm birth. Science 2003 300 5619 606-606
157. Watkins A J., Wilkins A, Cunningham C et al. Low protein diet fed exclusively during mouse oocyte maturation leads to behavioural and cardiovascular abnormalities in offspring. J Physiol 2008 586 8 2231-2244 (Pubitemid 351524574)
158. Sinclair K D., Allegrucci C, Singh R et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci U S A 2007 104 49 19351-19356
159. Watkins A J., Lucas E S., Torrens C et al. Maternal low protein diet during mouse pre-implantation development induces vascular dysfunction and altered renin-angiotensinsystem homeostasis in the offspring. Br J Nutr 2010 103 12 1762-1770
160. Woods L L., Ingelfinger J R., Nyengaard J R., Rasch R. Maternal protein restriction suppresses the newborn reninangiotensin system and programs adult hypertension in rats. Pediatr Res 2001 49 4 460-467 (Pubitemid 32274957)
161. Teklenburg G, Salker M, Molokhia M et al. Natural selection of human embryos: decidualizing endometrial stromal cells serve as sensors of embryo quality upon implantation. PLoS ONE 2010 5 4 e10258
162. Salker M, Teklenburg G, Molokhia M et al. Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss. PLoS ONE 2010 5 4 e10287
163. Teklenburg G, Salker M, Heijnen C, Macklon N S., Brosens J J. The molecular basis of recurrent pregnancy loss: impaired natural embryo selection. Mol Hum Reprod 2010 16 12 886-895
164. Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol 2003 15 6 465-471 (Pubitemid 38333555)